Percent changes in SUVpeak and size
| . | Responder . | . | Nonresponder . | . | ||
|---|---|---|---|---|---|---|
| . | Early . | Late . | Early . | Late . | ||
| ΔSUV (%) | −55 ± 19* | −76 ± 15* | −23 ± 41* | −34 ± 38* | ||
| ΔSize (%) | 1 ± 22 | −14 ± 25 | 2 ± 10 | −2 ± 23 | ||
| . | Responder . | . | Nonresponder . | . | ||
|---|---|---|---|---|---|---|
| . | Early . | Late . | Early . | Late . | ||
| ΔSUV (%) | −55 ± 19* | −76 ± 15* | −23 ± 41* | −34 ± 38* | ||
| ΔSize (%) | 1 ± 22 | −14 ± 25 | 2 ± 10 | −2 ± 23 | ||
NOTE: Early: PET/CT scan after first cycle of neoadjuvant therapy; Late: PET/CT scan after completion of neoadjuvant therapy.
P < 0.05 versus baseline SUVpeak.